Phosphorylation of the gastric tumor suppressor RUNX3 following H. pylori infection results in its localization to the cytoplasm

Journal of Cellular Physiology

Volumn 227, Issue 3, 2012, Pages 1071-1080

  Cinghu, Senthilkumar ^a   Goh, Yun Mi ^a,b   Oh, Byung Chul ^b   Lee, You Soub ^a   Lee, Ok Jun ^a   Devaraj, Halagowder ^c   Bae, Suk Chul ^a  

^a Chungbuk National University   (South Korea)

^b Gachon University   (South Korea)

^c UNIVERSITY OF MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; MUCIN 2; TRANSCRIPTION FACTOR RUNX; TRANSCRIPTION FACTOR RUNX3;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; GENE LOCATION; HELICOBACTER INFECTION; INTESTINE METAPLASIA; MALE; MOUSE; NONHUMAN; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH EPITHELIUM;

ANIMALS; CELL LINE, TUMOR; CORE BINDING FACTOR ALPHA 3 SUBUNIT; CYTOPLASM; FEMALE; GASTRIC MUCOSA; GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; STOMACH NEOPLASMS;

EID: 84155178030     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22820     Document Type: Article

References (31)

1. Babu SD, Jayanthi V, Devaraj N, Reis CA, Devaraj H. 2006. Expression profile of mucins (MUC2, MUC5AC and MUC6) in Helicobacter pylori infected pre-neoplastic and neoplastic human gastric epithelium. Mol Cancer 5: 10.
2. Bae SC, Ito Y. 2003. Comment on Levanon et al., "Runx3 knockouts and stomach cancer", in EMBO reports (June 2003). EMBO Rep 4: 538-539.
3. Beck F. 2004. The role of Cdx genes in the mammalian gut. Gut 53: 1394-1396.
4. Chi XZ, Yang JO, Lee KY, Ito K, Sakakura C, Li QL, Kim HR, Cha EJ, Lee YH, Kaneda A, Ushijima T, Kim WJ, Ito Y, Bae SC. 2005. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol Cell Biol 25: 8097-8107.
5. Correa P, Piazuelo MB, Wilson KT. 2010. Pathology of gastric intestinal metaplasia: Clinical implications. Am J Gastroenterol 105: 493-498.
6. Fainaru O, Woolf E, Lotem J, Yarmus M, Brenner O, Goldenberg D, Negreanu V, Bernstein Y, Levanon D, Jung S, Groner Y. 2004. Runx3 regulates mouse TGF-beta-mediated dendritic cell function and its absence results in airway inflammation. EMBO J 23: 969-979.
7. Fox JG, Rogers AB, Ihrig M, Taylor NS, Whary MT, Dockray G, Varro A, Wang TC. 2003. Helicobacter pylori-associated gastric cancer in INS-GAS mice is gender specific. Cancer Res 63: 942-950.
8. Fukamachi H. 2006. Runx3 controls growth and differentiation of gastric epithelial cells in mammals. Dev Growth Differ 48: 1-13.
9. Goh YM, Cinghu S, Hong ET, Lee YS, Kim JH, Jang JW, Li YH, Chi XZ, Lee KS, Wee H, Ito Y, Oh BC, Bae SC. 2010. Src kinase phosphorylates RUNX3 at tyrosine residues and localizes the protein in the cytoplasm. J Biol Chem 285: 10122-10129.
10. Hirayama F, Takagi S, Kusuhara H, Iwao E, Yokoyama Y, Ikeda Y. 1996. Induction of gastric ulcer and intestinal metaplasia in mongolian gerbils infected with Helicobacter pylori. J Gastroenterol 31: 755-757.
11. Inoue K, Ozaki S, Shiga T, Ito K, Masuda T, Okado N, Iseda T, Kawaguchi S, Ogawa M, Bae SC, Yamashita N, Itohara S, Kudo N, Ito Y. 2002. Runx3 controls the axonal projection of proprioceptive dorsal root ganglion neurons. Nat Neurosci 5: 946-954.
12. Ito Y. 2008. RUNX genes in development and cancer: Regulation of viral gene expression and the discovery of RUNX family genes. Adv Cancer Res 99: 33-76.
13. Ito K, Liu Q, Salto-Tellez M, Yano T, Tada K, Ida H, Huang C, Shah N, Inoue M, Rajnakova A, Hiong KC, Peh BK, Han HC, Ito T, Teh M, Yeoh KG, Ito Y. 2005. RUNX3, a novel tumor suppressor, is frequently inactivated in gastric cancer by protein mislocalization. Cancer Res 65: 7743-7750.
14. Ito K, Inoue KI, Bae SC, Ito Y. 2009. Runx3 expression in gastrointestinal tract epithelium: Resolving the controversy. Oncogene 28: 1379-1384.
15. Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, Konig W, Backert S. 2007. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature 449: 862-866.
16. Lee KS, Lee YS, Lee JM, Ito K, Cinghu S, Kim JH, Jang JW, Li YH, Goh YM, Chi XZ, Wee H, Lee HW, Hosoya A, Chung JH, Jang JJ, Kundu JK, Surh YJ, Kim WJ, Ito Y, Jung HS, Bae SC. 2010. Runx3 is required for the differentiation of lung epithelial cells and suppression of lung cancer. Oncogene 29: 3349-3361.
17. Lemke LB, Ge Z, Whary MT, Feng Y, Rogers AB, Muthupalani S, Fox JG. 2009. Concurrent Helicobacter bilis infection in C57BL/6 mice attenuates proinflammatory H. pylori-induced gastric pathology. Infect Immun 77: 2147-2158.
18. Levanon D, Brenner O, Otto F, Groner Y. 2003. Runx3 knockouts and stomach cancer. EMBO Rep 4: 560-564.
19. Li QL, Ito K, Sakakura C, Fukamachi H, Inoue K, Chi XZ, Lee KY, Nomura S, Lee CW, Han SB, Kim HM, Kim WJ, Yamamoto H, Yamashita N, Yano T, Ikeda T, Itohara S, Inazawa J, Abe T, Hagiwara A, Yamagishi H, Ooe A, Kaneda A, Sugimura T, Ushijima T, Bae SC, Ito Y. 2002. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 109: 113-124.
20. Lund AH, van Lohuizen M. 2002. RUNX: A trilogy of cancer genes. Cancer Cell 1: 213-215.
21. Mutoh H, Sakurai S, Satoh K, Osawa H, Hakamata Y, Takeuchi T, Sugano K. 2004. Cdx1 induced intestinal metaplasia in the transgenic mouse stomach: Comparative study with Cdx2 transgenic mice. Gut 53: 1416-1423.
22. Osaki M, Moriyama M, Adachi K, Nakada C, Takeda A, Inoue Y, Adachi H, Sato K, Oshimura M, Ito H. 2004. Expression of RUNX3 protein in human gastric mucosa, intestinal metaplasia and carcinoma. Eur J Clin Invest 34: 605-612.
23. Puig-Kroger A, Aguilera-Montilla N, Martinez-Nunez R, Dominguez-Soto A, Sanchez-Cabo F, Martin-Gayo E, Zaballos A, Toribio ML, Groner Y, Ito Y, Dopazo A, Corcuera MT, Alonso Martin MJ, Vega MA, Corbi AL. 2010. The novel RUNX3/p33 isoform is induced upon monocyte-derived dendritic cell maturation and downregulates IL-8 expression. Immunobiology 215: 812-820.
24. Reis CA, David L, Correa P, Carneiro F, de Bolos C, Garcia E, Mandel U, Clausen H, Sobrinho-Simoes M. 1999. Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. Cancer Res 59: 1003-1007.
25. Rogers AB, Taylor NS, Whary MT, Stefanich ED, Wang TC, Fox JG. 2005. Helicobacter pylori but not high salt induces gastric intraepithelial neoplasia in B6129 mice. Cancer Res 65: 10709-10715.
26. Saha A, Backert S, Hammond CE, Gooz M, Smolka AJ. 2010. Helicobacter pylori CagL activates ADAM17 to induce repression of the gastric H, K-ATPase alpha subunit. Gastroenterology 139: 239-248.
27. Selbach M, Moese S, Hurwitz R, Hauck CR, Meyer TF, Backert S. 2003. The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J 22: 515-528.
28. Taniuchi I, Sunshine MJ, Festenstein R, Littman DR. 2002. Evidence for distinct CD4 silencer functions at different stages of thymocyte differentiation. Mol Cell 10: 1083-1096.
29. Tatematsu M, Tsukamoto T, Inada K. 2003. Stem cells and gastric cancer: Role of gastric and intestinal mixed intestinal metaplasia. Cancer Sci 94: 135-141.
30. Tsukamoto T, Inada K, Tanaka H, Mizoshita T, Mihara M, Ushijima T, Yamamura Y, Nakamura S, Tatematsu M. 2004. Down-regulation of a gastric transcription factor, Sox2, and ectopic expression of intestinal homeobox genes, Cdx1 and Cdx2: Inverse correlation during progression from gastric/intestinal-mixed to complete intestinal metaplasia. J Cancer Res Clin Oncol 130: 135-145.
31. Weis VG, Goldenring JR. 2009. Current understanding of SPEM and its standing in the preneoplastic process. Gastric Cancer 12: 189-197.